Latest Advances

  • Condition: Metastatic Colon Cancer Following Renal Transplantation
  • Journal: Journal of medical case reports
  • Treatment Used: Chemotherapy and Targeted Therapy Supplemented with Stereotactic Radiotherapy
  • Number of Patients: 1
  • Published —
This case report describes the oncological treatment of a patient with renal transplantation, who presented with metastatic colon cancer 5 years after transplantation.
  • Condition: Transient Ischemic Attack (TIA) and Acute Ischemic Stroke (AIS)
  • Journal: JAMA
  • Treatment Used: Dual Antiplatelet Therapy with Aspirin and Clopidigrel, Anticoagulation Therapy, Intravenous Alteplase, Intravenous Recombinant Tissue Plasminogen Activator (IV rtPA), Mechanical Thrombectomy
  • Number of Patients: 0
  • Published —
This article discusses the various treatments for patients with transient ischemic attack (TIA) and acute ischemic stroke (AIS).
  • Condition: NRAS-Mutated Metastatic Melanoma
  • Journal: Journal of cancer research and therapeutics
  • Treatment Used: MEK inhibitor, Cobimetinib, First-Line Treatment
  • Number of Patients: 0
  • Published —
This case report described an 84-year-old patient diagnosed with NRAS-mutated metastatic melanoma treated with the MEK inhibitor, cobimentinib, as first-line treatment.
  • Condition: Atrial Fibrillation
  • Journal: Indian heart journal
  • Treatment Used: Complex Fractionated Electrogram Ablation
  • Number of Patients: 1034
  • Published —
The study researched the use of complex fractionated electrogram ablation for treating patients with atrial fibrillation.
  • Condition: Recurrence of Atrial Fibrillation (AF) after Catheter Ablation
  • Journal: Minerva cardiology and angiology
  • Treatment Used: Redo Ablation
  • Number of Patients: 0
  • Published —
This article discusses the treatment of recurrence of atrial fibrillation (heart quivering) after catheter ablation with redo ablation.
  • Condition: Relapsed or Refractory B-Cell Malignancies
  • Journal: Lancet (London, England)
  • Treatment Used: Pirtobrutinib
  • Number of Patients: 323
  • Published —
This study evaluated the safety and effectiveness of pirtobrutinib in the treatment of patients with relapsed or refractory B-cell malignancies.
  • Condition: Elective Hip and Knee Arthroplasty
  • Journal: Medicina (Kaunas, Lithuania)
  • Treatment Used: Chronic Antithrombotic Agents
  • Number of Patients: 0
  • Published —
This article discusses the use of chronic antithrombotic (anti-clot) agents in patients undergoing elective hip and knee arthroplasty (replacement).
  • Condition: Atrial Fibrillation
  • Journal: Journal of the American College of Cardiology
  • Treatment Used: Half-Dose vs. Full-Dose Edoxaban
  • Number of Patients: 14014
  • Published —
This study compared the outcome of lower dose edoxaban regimen (LDER) versus the higher dose edoxaban regimen (HDER) in patients with atrial fibrillation (heart quivering).
  • Condition: Chronic Kidney Disease
  • Journal: Current cardiology reports
  • Treatment Used: Apixaban or Direct Oral Anticoagulants versus Warfarin
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of apixaban and direct oral anticoagulants versus warfarin for chronic kidney disease.
  • Condition: Chronic Lymphocytic Leukemia (CLL)
  • Journal: Orvosi hetilap
  • Treatment Used: Ibrutinib and Venetoclax
  • Number of Patients: 0
  • Published —
This article discusses the treatment of patients with chronic lymphocytic leukemia (CLL).
  • Condition: Patients with Nonvalvular Atrial Fibrillation with Type 2 Diabetes
  • Journal: Cardiovascular diabetology
  • Treatment Used: Rivaroxaban vs. Warfarin
  • Number of Patients: 116049
  • Published —
This study evaluated the safety and effectiveness of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation (heart quivering) with type 2 diabetes.
Showing 1-12 of 1050